Commercial Real Estate Rebounds, but AI Concerns Stir Investor Jitters

Modern commercial office environment

Commercial real estate is surging back to life — and investors are paying attention. Yet even as dealmaking accelerates, a new wave of anxiety is spreading across the industry: the growing influence of AI.

Leaders from three of the world’s most powerful commercial brokerage firms — Hessam Nadji of Marcus & Millichap, Jay Hennick of Colliers, and Bob Sulentic of CBRE — reported impressive earnings, some hitting record highs. But earnings calls quickly shifted as analysts repeatedly questioned whether AI could disrupt brokerage, valuation, and high‑level transaction work.

“AI Can’t Replace Human Insight,” CEOs Say

Sulentic underscored that CBRE’s value is rooted in irreplaceable human relationships and advanced problem‑solving — far beyond anything automated systems can replicate. “We’re not selling $2 million condos,” he noted. “These are big, complex transactions that we’re doing.”

The bottom line: AI may assist, but it cannot replicate the decades of trust, nuance, and strategic negotiation behind commercial real estate deals.

Still, the concerns were enough to momentarily shake real estate stocks — continuing a broader pattern of AI‑driven volatility across multiple sectors.

Evidence of a Recovering Market

Despite AI anxiety, fundamentals remain strong. Office leasing is improving, lending jumped over 30% in the fourth quarter, and CBRE posted its highest revenue ever — surpassing $40 billion.

Hennick emphasized that AI is actually strengthening productivity at Colliers, while Nadji dismissed doomsday fears as “overly cautious,” calling full AI displacement “almost an impossible scenario.”

Where AI Helps — and Where It Won’t

Experts agree AI’s real power lies in data organization, underwriting, automation, and administrative tasks. Meanwhile, property tours, negotiations, and client advising remain firmly in human hands.

Nadji explained that AI already boosts underwriting speed and analysis: “There are countless ways AI is going to improve manual processes.” Still, he rejected predictions of empty office towers run entirely by machines.

Robert Shibuya of Mohr Partners echoed this, calling the stock‑market reaction an “overreaction.” AI can summarize a 40‑page lease in minutes — but no algorithm can walk a property, sense the environment, or negotiate a deal with human nuance.

For both new and seasoned professionals, the takeaway is clear: AI is a tool — not a replacement. Those who learn to leverage technology while mastering human‑driven skills will lead the next generation of CRE success.

This is where Cameron Academy excels — empowering professionals across Florida and the entire U.S. with the knowledge and training needed to stay competitive in an evolving market.

Source material inspired by CoStar News. Visit their original report for deeper insights and ongoing commercial real estate coverage.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments